David Roth, Chief Medical Officer: Syros Pharmaceuticals SYRS Sell · Filed 24/11/20

Trade details

Type: Insider sale
Amount: $2,419.8
Shares · price: 12,099 sh · $0.20 a share
Held after: 0 sh
Stock: Syros Pharmaceuticals SYRS
Person: David RothChief Medical Officer
Trade date: 24/11/18
Filed: 24/11/20
Days to filing: 2 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Syros Pharmaceuticals trades, last 26 weeks

What else happened in Syros Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/19~24/12/18

David Roth's recent trades

David RothChief Medical Officer
Sell10b5-1 planSyros Pharmaceuticals
Sell10b5-1 plan
Syros Pharmaceuticals
SYRS
$51.7K
10,451 sh
$51.7K
Filed 24/04/05
Traded 24/04/03
David RothChief Medical Officer
Sell10b5-1 planSyros Pharmaceuticals
Sell10b5-1 plan
Syros Pharmaceuticals
SYRS
$747
150 sh
$747
Filed 24/04/02
Traded 24/04/02
David RothChief Medical Officer
Sell10b5-1 planSyros Pharmaceuticals
Sell10b5-1 plan
Syros Pharmaceuticals
SYRS
$31.1K
6,287 sh
$31.1K
Filed 23/12/14
Traded 23/12/12
David RothChief Medical Officer
Sell10b5-1 planSyros Pharmaceuticals
Sell10b5-1 plan
Syros Pharmaceuticals
SYRS
$24.8K
6,287 sh
$24.8K
Filed 23/12/08
Traded 23/12/06
David RothChief Medical Officer
Sell10b5-1 planSyros Pharmaceuticals
Sell10b5-1 plan
Syros Pharmaceuticals
SYRS
$29K
7,348 sh
$29K
Filed 23/08/02
Traded 23/07/31